Hello, I am Kombo Gayus Habila, Lab Manager, Oncogenomics Laboratory, Lagos Nigeria. i am very glad to be here
-
-
Welcome GKombong! We're happy to have you join the community. Let us know if there is anything you need help with. -
Hi every one!. At Oncogenomics Lab we've being enjoying using Miseq FGX for sequencing and it was giving excellent results. But recently we received a new supply from our in-country suppliers. we used the reagents and had three consecutive test runs stopping after read 1. There was no error alarm or error code to that effect on the machine. In all the stopped runs, the quality metrics were excellent but till now we are yet to figure out whats wrong. Please has any body experience a similar problem? Meanwhile, the last run from the old stock of reagent didn't have any issue, the machine's available memory is 81% and no any alert for software update.Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM
Comment